Healthcare
Infinity Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
| Publication Date | June 2009 |
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 17 |
| ISBN Number | not applicable |
| Product Code | GMD02152 |
Summary
Infinity Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Infinity Pharmaceuticals, Inc. is engaged in the discovery, development and delivering the best-in-class medicines to patients for the treatment of cancer and related conditions. The company's programs develop from its innovative approach to drug discovery and broad range of research and development capabilities, including cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation. Its key product candidates include IPI-504 (Retaspimycin Hcl) for treating cancer, IPI-926 and IPI-493. The company is headquartered in Cambridge, Massachusetts of the United States.
Global Markets Direct's Infinity Pharmaceuticals, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Infinity Pharmaceuticals, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers' businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers - with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company's financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Contents
- Key Information
- Key Ratios
- Share Data
- Performance Chart
- List of Tables
- List of Figures
- Key Facts
- Business Description
- Major Products and Services
- Overview
- History
- SWOT Analysis Overview
- Overview
- Infinity Pharmaceuticals, Inc. - Strengths
- Focused Research and Development Operations
- Strong Financial Performance
- Orphan Drug Designation to IPI-504
- Infinity Pharmaceuticals, Inc. - Weaknesses
- Reliance on Third Party Manufacturers
- Infinity Pharmaceuticals, Inc. - Opportunities
- Hsp90 Inhibitor Program
- Pipeline Products
- Alliance with Purdue Pharma and Mundipharma
- Large Oncology Treatment Market
- Infinity Pharmaceuticals, Inc. - Threats
- Intense Competition
- Product Liability Claims
- Tightening of FDA's Regulatory Oversight
- Key Competitors
- Key Employees
- Key Employee Biographies
- Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Financial Ratios
- Capital Market Ratios
- Annual Ratios
- Interim Ratios
- Ratio Charts
- Appendix
- Methodology
- Ratio Definitions
- About Global Markets Direct
- Contact Us
- Disclaimer
- List of Tables
- Infinity Pharmaceuticals, Inc., Key Facts
- Infinity Pharmaceuticals, Inc., Key Ratios
- Infinity Pharmaceuticals, Inc., Share Data
- Infinity Pharmaceuticals, Inc., Key Facts
- Infinity Pharmaceuticals, Inc., History
- Infinity Pharmaceuticals, Inc., Key Employees
- Infinity Pharmaceuticals, Inc., Key Employee Biographies
- Infinity Pharmaceuticals, Inc., Subsidiaries
- Infinity Pharmaceuticals, Inc., Ratios based on current share price
- Infinity Pharmaceuticals, Inc., Annual Ratios
- Infinity Pharmaceuticals, Inc., Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Infinity Pharmaceuticals, Inc., Performance Chart (2004 - 2008)
- Infinity Pharmaceuticals, Inc., Ratio Charts








